[Comparison of the clinical characteristics and hospital treatment of myocardial infarction with and without ST-segment elevation in Hungary. National Registry of Myocardial Infarction].
BACKGROUND
Afew data have been published on the clinical characteristics of different types of myocardial infarction in Hungary.


OBJECTIVE
To compare clinical data of patients with ST-segment elevation and non-ST-segment elevation myocardial infarction based on the National Myocardial Infarction Registry database.


METHODS
Data recorded in the National Myocardial Infarction Registry between January 1, 2010 and June 30, 2012 were included in the analysis.


RESULTS
Patients treated with non-ST-segment elevation myocardial infarction (n = 5237) were older and had more comorbidities compared to those with ST-segment elevation myocardial infarction (n = 6670). Coronarography and percutaneous coronary intervention were performed more frequently in the latter group. There was no significant difference in in-hospital mortality between the two groups (5.3% and 4.9%). Medication for secondary prevention after myocardial infarction was applied in nearly 90% of the patients in both groups. Dual antiplatelet therapy was more often applied after ST-segment elevation myocardial infarction.


CONCLUSIONS
The study confirmed important differences in the clinical characteristics and similar hospital prognosis between the two patient groups.
Gottsegen György Országos Kardiológiai Intézet Budapest Haller u. 29. 1096.
Tamás
T
Breuer
Gottsegen György Országos Kardiológiai Intézet Budapest Haller u. 29. 1096.
András
A
Jánosi
Gottsegen György Országos Kardiológiai Intézet Budapest Haller u. 29. 1096.
Krisztina
K
Szüts
Gottsegen György Országos Kardiológiai Intézet Budapest Haller u. 29. 1096.
Péter
P
Andréka
Gottsegen György Országos Kardiológiai Intézet Budapest Haller u. 29. 1096.
Péter
P
Ofner
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D017023:Coronary Angiography; D003422:Critical Care / Q000379:methods*; D005260:Female; D006329:Heart Conduction System / Q000503:physiopathology*; D017052:Hospital Mortality; D006760:Hospitalization; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012042:Registries
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors
National Registry of Myocardial Infarction; Nemzeti Szívinfarktus Regiszter; clinical characteristics; halálozás; klinikai adatok; mortality; myocardial infarction; prognosis; prognózis; szívinfarktus